nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—SLC22A2—Progesterone—uterine cancer	0.312	0.428	CbGbCtD
Metoprolol—CYP2C19—Progesterone—uterine cancer	0.103	0.141	CbGbCtD
Metoprolol—ABCB1—Progesterone—uterine cancer	0.083	0.114	CbGbCtD
Metoprolol—CYP2D6—Progesterone—uterine cancer	0.0782	0.107	CbGbCtD
Metoprolol—ABCB1—Dactinomycin—uterine cancer	0.0658	0.0904	CbGbCtD
Metoprolol—ABCB1—Etoposide—uterine cancer	0.0371	0.051	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—uterine cancer	0.0253	0.0348	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—uterine cancer	0.0239	0.0328	CbGbCtD
Metoprolol—Chlorphenesin—CYP19A1—uterine cancer	0.00109	1	CrCbGaD
Metoprolol—Hepatic function abnormal—Epirubicin—uterine cancer	0.000462	0.00171	CcSEcCtD
Metoprolol—Photosensitivity—Epirubicin—uterine cancer	0.00046	0.0017	CcSEcCtD
Metoprolol—Dizziness—Progesterone—uterine cancer	0.000458	0.00169	CcSEcCtD
Metoprolol—Angiopathy—Etoposide—uterine cancer	0.000452	0.00167	CcSEcCtD
Metoprolol—Immune system disorder—Etoposide—uterine cancer	0.00045	0.00166	CcSEcCtD
Metoprolol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00045	0.00166	CcSEcCtD
Metoprolol—Mediastinal disorder—Etoposide—uterine cancer	0.000449	0.00166	CcSEcCtD
Metoprolol—Mental disability—Doxorubicin—uterine cancer	0.000447	0.00165	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000446	0.00165	CcSEcCtD
Metoprolol—Cardiac failure congestive—Epirubicin—uterine cancer	0.000445	0.00164	CcSEcCtD
Metoprolol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000444	0.00164	CcSEcCtD
Metoprolol—Alopecia—Etoposide—uterine cancer	0.00044	0.00163	CcSEcCtD
Metoprolol—Vomiting—Progesterone—uterine cancer	0.00044	0.00162	CcSEcCtD
Metoprolol—Rash—Progesterone—uterine cancer	0.000436	0.00161	CcSEcCtD
Metoprolol—Dermatitis—Progesterone—uterine cancer	0.000436	0.00161	CcSEcCtD
Metoprolol—Headache—Progesterone—uterine cancer	0.000434	0.0016	CcSEcCtD
Metoprolol—Hot flush—Epirubicin—uterine cancer	0.000432	0.00159	CcSEcCtD
Metoprolol—Diabetes mellitus—Doxorubicin—uterine cancer	0.00043	0.00159	CcSEcCtD
Metoprolol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.00158	CcSEcCtD
Metoprolol—Menopausal symptoms—Epirubicin—uterine cancer	0.000428	0.00158	CcSEcCtD
Metoprolol—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000428	0.00158	CcSEcCtD
Metoprolol—Photosensitivity—Doxorubicin—uterine cancer	0.000426	0.00157	CcSEcCtD
Metoprolol—Dysgeusia—Etoposide—uterine cancer	0.000425	0.00157	CcSEcCtD
Metoprolol—Fatigue—Dactinomycin—uterine cancer	0.000422	0.00156	CcSEcCtD
Metoprolol—Pain—Dactinomycin—uterine cancer	0.000418	0.00154	CcSEcCtD
Metoprolol—Muscle spasms—Etoposide—uterine cancer	0.000417	0.00154	CcSEcCtD
Metoprolol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000415	0.00153	CcSEcCtD
Metoprolol—Hypoglycaemia—Epirubicin—uterine cancer	0.000414	0.00153	CcSEcCtD
Metoprolol—Cardiac failure—Epirubicin—uterine cancer	0.000414	0.00153	CcSEcCtD
Metoprolol—Cerebrovascular accident—Epirubicin—uterine cancer	0.000412	0.00152	CcSEcCtD
Metoprolol—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000412	0.00152	CcSEcCtD
Metoprolol—Nausea—Progesterone—uterine cancer	0.000411	0.00152	CcSEcCtD
Metoprolol—Feeling abnormal—Dactinomycin—uterine cancer	0.000403	0.00149	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.0004	0.00148	CcSEcCtD
Metoprolol—Hot flush—Doxorubicin—uterine cancer	0.000399	0.00147	CcSEcCtD
Metoprolol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000399	0.00147	CcSEcCtD
Metoprolol—Affect lability—Epirubicin—uterine cancer	0.000398	0.00147	CcSEcCtD
Metoprolol—Menopausal symptoms—Doxorubicin—uterine cancer	0.000396	0.00146	CcSEcCtD
Metoprolol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000395	0.00146	CcSEcCtD
Metoprolol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000395	0.00146	CcSEcCtD
Metoprolol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00145	CcSEcCtD
Metoprolol—Vertigo—Etoposide—uterine cancer	0.00039	0.00144	CcSEcCtD
Metoprolol—Leukopenia—Etoposide—uterine cancer	0.000388	0.00143	CcSEcCtD
Metoprolol—Abdominal pain—Dactinomycin—uterine cancer	0.000387	0.00143	CcSEcCtD
Metoprolol—Body temperature increased—Dactinomycin—uterine cancer	0.000387	0.00143	CcSEcCtD
Metoprolol—Cardiac arrest—Epirubicin—uterine cancer	0.000384	0.00142	CcSEcCtD
Metoprolol—Cardiac failure—Doxorubicin—uterine cancer	0.000383	0.00141	CcSEcCtD
Metoprolol—Hypoglycaemia—Doxorubicin—uterine cancer	0.000383	0.00141	CcSEcCtD
Metoprolol—Mood swings—Epirubicin—uterine cancer	0.000383	0.00141	CcSEcCtD
Metoprolol—Loss of consciousness—Etoposide—uterine cancer	0.000381	0.00141	CcSEcCtD
Metoprolol—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000381	0.00141	CcSEcCtD
Metoprolol—Hypertension—Etoposide—uterine cancer	0.000375	0.00138	CcSEcCtD
Metoprolol—Liver function test abnormal—Epirubicin—uterine cancer	0.000373	0.00138	CcSEcCtD
Metoprolol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000373	0.00138	CcSEcCtD
Metoprolol—Chest pain—Etoposide—uterine cancer	0.000369	0.00136	CcSEcCtD
Metoprolol—Orthostatic hypotension—Epirubicin—uterine cancer	0.000369	0.00136	CcSEcCtD
Metoprolol—Abdominal pain upper—Epirubicin—uterine cancer	0.000369	0.00136	CcSEcCtD
Metoprolol—Affect lability—Doxorubicin—uterine cancer	0.000368	0.00136	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000367	0.00135	CcSEcCtD
Metoprolol—Breast disorder—Epirubicin—uterine cancer	0.000365	0.00135	CcSEcCtD
Metoprolol—Hypersensitivity—Dactinomycin—uterine cancer	0.00036	0.00133	CcSEcCtD
Metoprolol—Confusional state—Etoposide—uterine cancer	0.000357	0.00132	CcSEcCtD
Metoprolol—Cardiac arrest—Doxorubicin—uterine cancer	0.000355	0.00131	CcSEcCtD
Metoprolol—Mood swings—Doxorubicin—uterine cancer	0.000354	0.00131	CcSEcCtD
Metoprolol—Asthenia—Dactinomycin—uterine cancer	0.000351	0.0013	CcSEcCtD
Metoprolol—Thrombocytopenia—Etoposide—uterine cancer	0.000347	0.00128	CcSEcCtD
Metoprolol—Tachycardia—Etoposide—uterine cancer	0.000346	0.00128	CcSEcCtD
Metoprolol—Liver function test abnormal—Doxorubicin—uterine cancer	0.000345	0.00127	CcSEcCtD
Metoprolol—Skin disorder—Etoposide—uterine cancer	0.000344	0.00127	CcSEcCtD
Metoprolol—Hyperhidrosis—Etoposide—uterine cancer	0.000342	0.00126	CcSEcCtD
Metoprolol—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000341	0.00126	CcSEcCtD
Metoprolol—Abdominal pain upper—Doxorubicin—uterine cancer	0.000341	0.00126	CcSEcCtD
Metoprolol—Angina pectoris—Epirubicin—uterine cancer	0.00034	0.00126	CcSEcCtD
Metoprolol—Breast disorder—Doxorubicin—uterine cancer	0.000338	0.00125	CcSEcCtD
Metoprolol—Diarrhoea—Dactinomycin—uterine cancer	0.000335	0.00124	CcSEcCtD
Metoprolol—Hypotension—Etoposide—uterine cancer	0.000331	0.00122	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—uterine cancer	0.000319	0.00118	CcSEcCtD
Metoprolol—Paraesthesia—Etoposide—uterine cancer	0.000318	0.00117	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—uterine cancer	0.000318	0.00117	CcSEcCtD
Metoprolol—Dyspnoea—Etoposide—uterine cancer	0.000316	0.00117	CcSEcCtD
Metoprolol—Somnolence—Etoposide—uterine cancer	0.000315	0.00116	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—uterine cancer	0.000315	0.00116	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—uterine cancer	0.000313	0.00116	CcSEcCtD
Metoprolol—Vomiting—Dactinomycin—uterine cancer	0.000311	0.00115	CcSEcCtD
Metoprolol—Rash—Dactinomycin—uterine cancer	0.000308	0.00114	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Etoposide—uterine cancer	0.000306	0.00113	CcSEcCtD
Metoprolol—Fatigue—Etoposide—uterine cancer	0.000305	0.00113	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—uterine cancer	0.000303	0.00112	CcSEcCtD
Metoprolol—Pain—Etoposide—uterine cancer	0.000303	0.00112	CcSEcCtD
Metoprolol—Constipation—Etoposide—uterine cancer	0.000303	0.00112	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—uterine cancer	0.000303	0.00112	CcSEcCtD
Metoprolol—Sweating—Epirubicin—uterine cancer	0.000298	0.0011	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000295	0.00109	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—uterine cancer	0.000294	0.00109	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—uterine cancer	0.000294	0.00109	CcSEcCtD
Metoprolol—Feeling abnormal—Etoposide—uterine cancer	0.000292	0.00108	CcSEcCtD
Metoprolol—Nausea—Dactinomycin—uterine cancer	0.000291	0.00107	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—uterine cancer	0.00029	0.00107	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—uterine cancer	0.00029	0.00107	CcSEcCtD
Metoprolol—Gastrointestinal pain—Etoposide—uterine cancer	0.00029	0.00107	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—uterine cancer	0.000284	0.00105	CcSEcCtD
Metoprolol—Urticaria—Etoposide—uterine cancer	0.000281	0.00104	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—uterine cancer	0.000281	0.00104	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—uterine cancer	0.00028	0.00103	CcSEcCtD
Metoprolol—Abdominal pain—Etoposide—uterine cancer	0.00028	0.00103	CcSEcCtD
Metoprolol—Body temperature increased—Etoposide—uterine cancer	0.00028	0.00103	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—uterine cancer	0.00028	0.00103	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—uterine cancer	0.000279	0.00103	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—uterine cancer	0.000276	0.00102	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—uterine cancer	0.000275	0.00102	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—uterine cancer	0.000275	0.00101	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000272	0.00101	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—uterine cancer	0.000269	0.000994	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—uterine cancer	0.000269	0.000992	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—uterine cancer	0.000263	0.000972	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—uterine cancer	0.000261	0.000964	CcSEcCtD
Metoprolol—Hypersensitivity—Etoposide—uterine cancer	0.000261	0.000963	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—uterine cancer	0.00026	0.000962	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—uterine cancer	0.000259	0.000957	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—uterine cancer	0.000259	0.000957	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—uterine cancer	0.000259	0.000954	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—uterine cancer	0.000255	0.00094	CcSEcCtD
Metoprolol—Asthenia—Etoposide—uterine cancer	0.000254	0.000938	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—uterine cancer	0.000254	0.000938	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—uterine cancer	0.000253	0.000936	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—uterine cancer	0.000252	0.000932	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—uterine cancer	0.000252	0.00093	CcSEcCtD
Metoprolol—Pruritus—Etoposide—uterine cancer	0.000251	0.000925	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—uterine cancer	0.00025	0.000921	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—uterine cancer	0.000249	0.00092	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—uterine cancer	0.000247	0.000911	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—uterine cancer	0.000245	0.000904	CcSEcCtD
Metoprolol—Diarrhoea—Etoposide—uterine cancer	0.000242	0.000894	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—uterine cancer	0.000242	0.000892	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—uterine cancer	0.000241	0.00089	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—uterine cancer	0.00024	0.000886	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—uterine cancer	0.00024	0.000885	CcSEcCtD
Metoprolol—Tension—Epirubicin—uterine cancer	0.000239	0.000881	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—uterine cancer	0.000238	0.000879	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—uterine cancer	0.000236	0.000872	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—uterine cancer	0.000235	0.000866	CcSEcCtD
Metoprolol—Dizziness—Etoposide—uterine cancer	0.000234	0.000865	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—uterine cancer	0.000234	0.000863	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—uterine cancer	0.000233	0.000862	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—uterine cancer	0.000233	0.00086	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—uterine cancer	0.000231	0.000853	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—uterine cancer	0.000229	0.000846	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—uterine cancer	0.000228	0.000843	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—uterine cancer	0.000226	0.000836	CcSEcCtD
Metoprolol—Vomiting—Etoposide—uterine cancer	0.000225	0.000831	CcSEcCtD
Metoprolol—Rash—Etoposide—uterine cancer	0.000223	0.000824	CcSEcCtD
Metoprolol—Dermatitis—Etoposide—uterine cancer	0.000223	0.000824	CcSEcCtD
Metoprolol—Headache—Etoposide—uterine cancer	0.000222	0.000819	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—uterine cancer	0.000222	0.000819	CcSEcCtD
Metoprolol—Tension—Doxorubicin—uterine cancer	0.000221	0.000815	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—uterine cancer	0.00022	0.000814	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—uterine cancer	0.000219	0.000807	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—uterine cancer	0.000219	0.000807	CcSEcCtD
Metoprolol—Syncope—Epirubicin—uterine cancer	0.000218	0.000805	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—uterine cancer	0.000218	0.000804	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—uterine cancer	0.000216	0.000799	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—uterine cancer	0.000215	0.000794	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—uterine cancer	0.000214	0.000789	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—uterine cancer	0.000212	0.000783	CcSEcCtD
Metoprolol—Nausea—Etoposide—uterine cancer	0.00021	0.000777	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—uterine cancer	0.00021	0.000775	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—uterine cancer	0.000207	0.000764	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—uterine cancer	0.000207	0.000764	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—uterine cancer	0.000206	0.000762	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000206	0.000759	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—uterine cancer	0.000202	0.000748	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—uterine cancer	0.000202	0.000746	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—uterine cancer	0.000202	0.000745	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—uterine cancer	0.000201	0.000744	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—uterine cancer	0.0002	0.000739	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—uterine cancer	0.000199	0.000734	CcSEcCtD
Metoprolol—Oedema—Epirubicin—uterine cancer	0.000198	0.000733	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—uterine cancer	0.000198	0.00073	CcSEcCtD
Metoprolol—Shock—Epirubicin—uterine cancer	0.000195	0.000721	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—uterine cancer	0.000195	0.000719	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—uterine cancer	0.000194	0.000718	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—uterine cancer	0.000194	0.000717	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—uterine cancer	0.000194	0.000715	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—uterine cancer	0.000193	0.000712	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—uterine cancer	0.000192	0.000708	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—uterine cancer	0.000192	0.000707	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—uterine cancer	0.000192	0.000707	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—uterine cancer	0.000191	0.000705	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00019	0.000702	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—uterine cancer	0.000187	0.000692	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—uterine cancer	0.000185	0.000685	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—uterine cancer	0.000185	0.000684	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—uterine cancer	0.000184	0.000678	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000181	0.000668	CcSEcCtD
Metoprolol—Shock—Doxorubicin—uterine cancer	0.000181	0.000667	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—uterine cancer	0.00018	0.000665	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—uterine cancer	0.00018	0.000664	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—uterine cancer	0.00018	0.000663	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—uterine cancer	0.000179	0.000662	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—uterine cancer	0.000178	0.000659	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—uterine cancer	0.000178	0.000658	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—uterine cancer	0.000178	0.000656	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—uterine cancer	0.000177	0.000653	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—uterine cancer	0.000176	0.000651	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—uterine cancer	0.000175	0.000645	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—uterine cancer	0.000172	0.000634	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000171	0.000633	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—uterine cancer	0.000171	0.000632	CcSEcCtD
Metoprolol—Constipation—Epirubicin—uterine cancer	0.00017	0.000627	CcSEcCtD
Metoprolol—Pain—Epirubicin—uterine cancer	0.00017	0.000627	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000167	0.000618	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—uterine cancer	0.000166	0.000613	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—uterine cancer	0.000165	0.000609	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—uterine cancer	0.000164	0.000605	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—uterine cancer	0.000164	0.000604	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—uterine cancer	0.000163	0.000603	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—uterine cancer	0.000162	0.000599	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—uterine cancer	0.000162	0.000597	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000159	0.000585	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—uterine cancer	0.000158	0.000585	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—uterine cancer	0.000158	0.000582	CcSEcCtD
Metoprolol—Pain—Doxorubicin—uterine cancer	0.000157	0.00058	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—uterine cancer	0.000157	0.00058	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—uterine cancer	0.000157	0.000579	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—uterine cancer	0.000157	0.000579	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—uterine cancer	0.000151	0.000559	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00015	0.000554	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—uterine cancer	0.000146	0.00054	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—uterine cancer	0.000146	0.000539	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—uterine cancer	0.000145	0.000536	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—uterine cancer	0.000145	0.000536	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—uterine cancer	0.000142	0.000526	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—uterine cancer	0.00014	0.000518	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—uterine cancer	0.000136	0.000501	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—uterine cancer	0.000135	0.0005	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—uterine cancer	0.000132	0.000486	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—uterine cancer	0.000131	0.000485	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—uterine cancer	0.00013	0.00048	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—uterine cancer	0.000126	0.000466	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—uterine cancer	0.000126	0.000464	CcSEcCtD
Metoprolol—Rash—Epirubicin—uterine cancer	0.000125	0.000462	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—uterine cancer	0.000125	0.000462	CcSEcCtD
Metoprolol—Headache—Epirubicin—uterine cancer	0.000124	0.000459	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—uterine cancer	0.000121	0.000448	CcSEcCtD
Metoprolol—Nausea—Epirubicin—uterine cancer	0.000118	0.000435	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—uterine cancer	0.000117	0.000431	CcSEcCtD
Metoprolol—Rash—Doxorubicin—uterine cancer	0.000116	0.000428	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—uterine cancer	0.000116	0.000427	CcSEcCtD
Metoprolol—Headache—Doxorubicin—uterine cancer	0.000115	0.000425	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—uterine cancer	0.000109	0.000403	CcSEcCtD
